<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>GBIHealth | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-26T11:25:34+08:00</updated>
  <subtitle>GBI专注于中国市场，为药企、器械企业和其他服务提供商建立多元的市场情报解决方案组合。GBI的高附加值行业信息、新闻和数据服务能力帮助个人和组织做出以数据为驱动的决策，更高效地沟通。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>带量采购 | 山东大汉，一降到底；湖南辣妹，死磕注射剂；高值耗材，第二波儿来袭！</title>
    <updated>2020-11-25T19:44:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/jXumSqVmi_Mko-e9Wq_QXg</id>
    <link href="https://mp.weixin.qq.com/s/jXumSqVmi_Mko-e9Wq_QXg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默沙东达成4.25亿美元现金交易；礼来BTK抑制剂获批临床；石药首创在研药获FDA孤儿药资格认定</title>
    <updated>2020-11-25T19:44:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/8ZO0orr6jDC1Q4NdzDmuLg</id>
    <link href="https://mp.weixin.qq.com/s/8ZO0orr6jDC1Q4NdzDmuLg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来巴瑞替尼获FDA紧急使用授权；诺华奥法妥木单抗进入优先审评；恒瑞两款新药拟纳入突破性治疗品种；武田安吉优获批上市</title>
    <updated>2020-11-24T22:38:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/uEo-PpXtVvkMsRgDjmCQ8w</id>
    <link href="https://mp.weixin.qq.com/s/uEo-PpXtVvkMsRgDjmCQ8w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新药研发，如何定位生物药靶点才能又快又准？</title>
    <updated>2020-11-24T22:38:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/Y6FQfR_y1rcEXBfI5WZu5A</id>
    <link href="https://mp.weixin.qq.com/s/Y6FQfR_y1rcEXBfI5WZu5A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保局发布医药价格和招采信用评价；BMS一线药拟纳入优先审评；再生元抗体药获FDA紧急使用授权；诺华与Mesoblast达成合作</title>
    <updated>2020-11-23T18:18:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/2W68SipZxFoGjdk_uH5IOg</id>
    <link href="https://mp.weixin.qq.com/s/2W68SipZxFoGjdk_uH5IOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 武田血友病管理工具myPKFiT获批；FDA批准首个家用新冠试剂盒</title>
    <updated>2020-11-23T18:18:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/l-u8gEF_Dyqe0cjZH1rlcQ</id>
    <link href="https://mp.weixin.qq.com/s/l-u8gEF_Dyqe0cjZH1rlcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>议程公开 | 2020第三届中国生物医药创新合作大会</title>
    <updated>2020-11-23T18:18:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/Gxyc3R9zbYrWzOVsa4o55Q</id>
    <link href="https://mp.weixin.qq.com/s/Gxyc3R9zbYrWzOVsa4o55Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>会议精选 | 第九届中国医药决策科学峰会暨CphMRA 2020年度会议</title>
    <updated>2020-11-22T17:54:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/1QBpOnxMSS8KkZHfE3KjEg</id>
    <link href="https://mp.weixin.qq.com/s/1QBpOnxMSS8KkZHfE3KjEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家药监局药审中心发布重磅政策；第三款RNAi药物获欧盟批准；首个早衰症治疗药物获FDA批准；先声药业引进的1类新药获批临床</title>
    <updated>2020-11-22T17:54:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/rCFIgpFQk9KO_ghIT36jYA</id>
    <link href="https://mp.weixin.qq.com/s/rCFIgpFQk9KO_ghIT36jYA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>县域医药市场发展及影响因素</title>
    <updated>2020-11-22T17:54:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/636kEs6XC5cGJHBnW9gPXQ</id>
    <link href="https://mp.weixin.qq.com/s/636kEs6XC5cGJHBnW9gPXQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最落地的数据产能创新 | 从快消产业到医疗健康 资源极端紧缩下的生存方式</title>
    <updated>2020-11-20T01:37:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/IXSbLWA6K8_o8hu3xURkZA</id>
    <link href="https://mp.weixin.qq.com/s/IXSbLWA6K8_o8hu3xURkZA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首个国产ALK抑制剂获批上市！武田中国与至本医疗达成合作；恩格列净新适应症上市申请获受理</title>
    <updated>2020-11-20T01:37:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/GxfOMjkc7jSHiWtNgBdddw</id>
    <link href="https://mp.weixin.qq.com/s/GxfOMjkc7jSHiWtNgBdddw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>会议精选 |【新体制】监管科学兴起 中国医药创新之路如何披荆斩棘</title>
    <updated>2020-11-20T01:37:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/cG3Ogn0lMvT63irfCm2dgQ</id>
    <link href="https://mp.weixin.qq.com/s/cG3Ogn0lMvT63irfCm2dgQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国采点名，没你不行！10亿市场重磅品种满3家过评，33个品种纳入地方集采，注射剂国采说来就来</title>
    <updated>2020-11-18T17:59:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/FCJ61WK5VKyH3wFMPYnwww</id>
    <link href="https://mp.weixin.qq.com/s/FCJ61WK5VKyH3wFMPYnwww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>拜耳首创药物申请上市；默沙东抗感染新药申报上市；MSD与Akrikhin达成合作；恒瑞2.2类新药获批临试；罗氏达成研发合作</title>
    <updated>2020-11-18T17:59:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/KhWxT1pORPAlmE46hkbiGQ</id>
    <link href="https://mp.weixin.qq.com/s/KhWxT1pORPAlmE46hkbiGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT |  药监局发布国家医疗器械监督抽检结果通告；上海微创医疗器械（集团）有限公司多点开花进军厄瓜多尔</title>
    <updated>2020-11-18T17:59:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/GEFGOPhWX1KIZjMESKjcRg</id>
    <link href="https://mp.weixin.qq.com/s/GEFGOPhWX1KIZjMESKjcRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>数字化时代用眼告急！催生眼科药物深蓝海</title>
    <updated>2020-11-17T17:29:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/mscirkid0kSXnJipNLf4MA</id>
    <link href="https://mp.weixin.qq.com/s/mscirkid0kSXnJipNLf4MA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>万春医药或打破30年空白，百济神州获批临试；全球首个皮下注射PD-L1抗体提交上市申请；Dicerna公布RNAi疗法试验结果</title>
    <updated>2020-11-17T17:29:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/drcJL_lGlUnWGs7-c32kgA</id>
    <link href="https://mp.weixin.qq.com/s/drcJL_lGlUnWGs7-c32kgA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 药监局公开征求医疗器械分类目录动态调整工作意见；赛诺医疗公布新一代药物洗脱支架PIONEER-Ⅲ临试随访数据</title>
    <updated>2020-11-17T17:29:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/oBtqlhc4v-8nJ0ks94iw_w</id>
    <link href="https://mp.weixin.qq.com/s/oBtqlhc4v-8nJ0ks94iw_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MSD Keytruda获FDA批准；赛诺菲创新药在中国商业上市；信达生物公布IBI302 I期临床结果；百济赴上交所科创板上市</title>
    <updated>2020-11-16T21:12:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/GYDgNldjozJpEMd8czFNzg</id>
    <link href="https://mp.weixin.qq.com/s/GYDgNldjozJpEMd8czFNzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>